Researchers have identified a biomarker that can help determine which medlinkrenal cancer/medlink patients are at a higher risk of recurrence. The
Vous n'êtes pas connecté
Researchers at the University of Michigan Rogel Cancer Center have developed a 15-gene signature that helps classify clear cell kidney cancer patients from low to high risk of recurrence. Research results published At JCO Precision Oncology. Scientists announced that kidney cancer accounts for approximately 3-5% of all cancer cases. Clear cell kidney cancer is the […]
Researchers have identified a biomarker that can help determine which medlinkrenal cancer/medlink patients are at a higher risk of recurrence. The
The gene signature for renal cancer can help clinicians identify recurrence risk earlier and potentially guide patient treatment strategies.
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice.
A discovery by researchers at the University of British Columbia, Canada, promises to improve care for patients with endometrial cancer, the most...
Researchers from the University of Helsinki and HUS investigated the effects of recurring mutations in the KLHL6 gene in diffuse large B-cell...
Researchers at the University of Gothenburg have developed an AI model that increases the potential for detecting cancer through sugar analyses
A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at...
Malaysia is currently the country with the second highest percentage of people with obesity problems in Southeast Asia after Brunei. This also causes...